Dr. Saoirse Elizabeth O’Sullivan

Haemodynamic effects of Cannabidiol in humans, PROFESSOR, UNIVERSITY OF NOTTINGHAM

Dr. Saoirse Elizabeth O’Sullivan received her doctorate from Trinity College Dublin in 2001 and moved to the University of Nottingham in 2002 as a Research fellow where she began researching cannabinoid pharmacology through basic and clinical research. She was made Lecturer in 2007 and Associate Professor in 2011. She has over 30 original research articles, 6 systematic reviews/meta-analyses, 7 reviews and 3 books chapters on the topic of cannabinoid pharmacology. Her specific interests are on the effects of cannabinoids on the cardiovascular and gastrointestinal system, and therapeutic potential of cannabis-based medicines in disorders such as stroke, diabetes, and inflammatory bowel disease. Her research methodologies span from cellular and animal models, to human healthy volunteer studies and early phase clinical trials. In 2016 she was named the International Cannabinoid Research Society Young Investigator of the Year. Saoirse runs an independent consulting company called CanPharmaConsulting Ltd, through this acts as a scientific advisor to Artelo Biosciences and Dragonfly Biosciences and is the science lead for the Centre for Medicine Cannabis (CMC), a non-profit organisation working to shape the UK’s new medicinal cannabis regime in the interests of patient.